VFY – Vitrafy Life Sciences
Vitrafy has designed and developed an innovative solution for the advancement of cryopreservation, which includes smart devices, a sample quality management software platform, and smart packaging solutions.
Vitrafy’s Cryopreservation Technology has been proven to substantially increase cell survival and functionality when compared to many industry and regulatory standards via internal testing and third‑party validation studies.
Vitrafy is headquartered in Melbourne, Australia. In addition, the Company has operations in Ballarat, Victoria, which provides a fully operational laboratory, engineering, and an ISO 13485‑certified manufacturing facility. As the Company grows, Vitrafy will look to expand into the United States, as well as partner with an outsourced manufacturer to build and develop its smart devices.
It is anticipated that VFY will list on the ASX during November 2024.
Vitrafy – Life Sciences – Vitrafy
pioneering technology, preserving life. We’re addressing a vital global need. Every year, thousands of people suffer due to the lack of available healthcare treatments. Cryopreservation is a process that preserves biomaterials for future use by cooling the samples to very low temperatures…
vitrafy.com
Source link
